Literature DB >> 33598868

Weight fluctuation and risk of hepatocellular carcinoma: a nationwide population-based 8-million-subject study.

Young Chang1, Jeong-Ju Yoo2, Dong Wook Shin3,4, Su Jong Yu5, Eun Ju Cho6, Kyungdo Han7, Dahye Kim7, Bo-Yeon Kim8, Goh Eun Chung9, Yuri Cho10.   

Abstract

BACKGROUND/AIM: The importance of hepatocellular carcinoma (HCC) caused by obesity has been emphasized. Many studies have shown that weight fluctuations as well as high BMI are associated with various adverse outcomes. In this study, we investigated the relationship between weight fluctuation and HCC in general populations drawn from a nationwide population-based cohort.
METHOD: A population-based cohort study including 8,001,829 subjects participating in more than three health examinations within 5 years from the index year were followed until the end of 2017. The degree of weight fluctuation and incidence of HCC during the period were evaluated.
RESULTS: When we classified groups according to baseline body mass index (BMI) level, the highest risk for HCC was observed in subjects with BMI of 30 or greater (adjusted hazard ratio [aHR] 1.40, 95% confidence interval [CI] 1.27-1.54). Also, increasing trends for the relationship between weight fluctuation and HCC were observed in multivariable Cox proportional analyses. The risk of HCC increased by 16% (aHR 1.16, 95% CI 1.12-1.20) for the highest quartile of weight fluctuation relative to the lowest quartile. These findings were consistent regardless of the baseline BMI or other metabolic factors. However, these effects of weight fluctuation on HCC were not observed in liver cirrhosis or viral hepatitis subgroups.
CONCLUSION: Weight fluctuation is an independent predictor of HCC. In the absence of liver cirrhosis or chronic hepatitis, the impact of weight fluctuation on HCC is further emphasized. These results suggest maintaining steady weight is recommended to reduce the risk of HCC.

Entities:  

Keywords:  Body mass index; Diabetes; Fatty liver; Fluctuation; Hepatocellular carcinoma; Inflammation; Metabolic dysfunction; Obesity; Telomere; Weight

Year:  2021        PMID: 33598868     DOI: 10.1007/s12072-021-10149-y

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  1 in total

1.  Impact of weight cycling on CTRP3 expression, adipose tissue inflammation and insulin sensitivity in C57BL/6J mice.

Authors:  Xin Li; Li Jiang; Miao Yang; Yu-Wen Wu; Jia-Zhong Sun
Journal:  Exp Ther Med       Date:  2018-07-04       Impact factor: 2.447

  1 in total
  2 in total

1.  The Change in Metabolic Syndrome Status and the Risk of Nonviral Liver Cirrhosis.

Authors:  Goh-Eun Chung; Young Chang; Yuri Cho; Eun-Ju Cho; Jeong-Ju Yoo; Sang-Hyun Park; Kyungdo Han; Dong-Wook Shin; Su-Jong Yu; Yoon-Jun Kim; Jung-Hwan Yoon
Journal:  Biomedicines       Date:  2021-12-20

2.  Association of Metabolic Parameter Variability with Esophageal Cancer Risk: A Nationwide Population-Based Study.

Authors:  Ji Eun Lee; Kyungdo Han; Juhwan Yoo; Yohwan Yeo; In Young Cho; Belong Cho; Hyuktae Kwon; Dong Wook Shin; Jong Ho Cho; Yong-Moon Park
Journal:  J Pers Med       Date:  2022-03-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.